Celgene Corp (NASDAQ:CELG)

87.15
Data as of Jul 31
 -1.19 / -1.35%
Today’s Change
65.76
Today|||52-Week Range
90.50
+3.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$70.6B

Company Description

Celgene Corp. engages in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. It is dedicated to innovative research and development, which is designed to bring new therapies to market and is involved in research in several scientific areas such as immunomodulation and intracellular signaling pathways in hematology, oncology and immune-inflammatory diseases. The company's commercial stage products include Revlimid, Vidaza, Thalomid Abraxane and Istodax. Celgene was founded in 1986 and is headquartered in Summit, NJ.

Contact Information

Celgene Corp.
86 Morris Avenue
Summit New Jersey 07901
P:(908) 673-9000
Investor Relations:
(908) 673-9530

Employees

Shareholders

Other institutional42.27%
Mutual fund holders40.62%
Individual stakeholders1.18%

Top Executives

Robert J. HuginChairman & Chief Executive Officer
Perry A. KarsenChief Operating Officer & Executive Vice President
Jacqualyn A. FouseChief Financial Officer & Executive Vice President
Jerome Bernard ZeldisChief Medical Officer & CEO-Global Health
Thomas O. DanielEVP, President-Research & Early Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.